RVL Pharmaceuticals plc/ IE00BF2HDL56 /
2023-10-20 10:00:00 PM | Chg. - | Volume | Bid1:59:46 AM | Ask1:59:59 AM | High | Low |
---|---|---|---|---|---|---|
0.0282USD | - | 63.96 mill. Turnover: 1.39 mill. |
0.0220Bid Size: 31,100 | 0.0221Ask Size: 8,500 | 0.0380 | 0.0270 |
GlobeNewswire
2023-11-17
Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition C...
GlobeNewswire
2023-10-12
RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
GlobeNewswire
2023-08-23
RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
2023-08-16
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under N...
GlobeNewswire
2022-03-23
RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full Year 2021 Financial Results and Provide F...
GlobeNewswire
2022-03-09
RVL Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2022
GlobeNewswire
2022-01-19
UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, Ne...
GlobeNewswire
2022-01-19
Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker ...
GlobeNewswire
2022-01-18
RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022
GlobeNewswire
2022-01-06
Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022
GlobeNewswire
2021-12-20
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference
GlobeNewswire
2021-11-15
Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business Update
GlobeNewswire
2021-11-15
Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021
GlobeNewswire
2021-11-12
Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November...
GlobeNewswire
2021-10-13
Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offering
GlobeNewswire
2021-10-07
Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100...
GlobeNewswire
2021-10-07
Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public Offering
GlobeNewswire
2021-10-06
Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public Offering
GlobeNewswire
2021-09-22
Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021
GlobeNewswire
2021-09-02
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
2021-08-30
Osmotica Pharmaceuticals plc Closes Sale of Legacy Business to Alora Pharmaceuticals, LLC
GlobeNewswire
2021-08-16
Osmotica Pharmaceuticals plc Reports Second Quarter 2021 Results and Provides Business Update